慢性阻害性肺疾患のスクリーニング:米国予防サービスタスクフォースの最新証拠報告と体系的レビュー
Elizabeth M Webber1, Jennifer S Lin1, Rachel G Thomas1
1Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
JAMA
|May 10, 2022
まとめ
このレビューでは,慢性閉塞性肺疾患 (COPD) のスクリーニングの有効性に関する新しい証拠は見つかりませんでした. 中程度のCOPDの薬剤治療は効果を示したが,非薬剤治療は一貫して結果を改善しなかった.
科学分野:
- 肺医学
- 予防的な心臓科
- 証拠 に 基づく 医学
背景:
- 慢性閉塞性肺疾患 (COPD) は,米国における重大な病気と死因です.
- COPDのスクリーニングと治療に関する勧告を基に,最新の証拠が必要である.
研究 の 目的:
- COPDのスクリーニングと治療の有効性に関する証拠を更新するために,標的を絞った体系的なレビューを実施する.
- 米国予防サービスタスクフォース (USPSTF) に2016年の勧告声明の更新を通知する.
主な方法:
- 2015年1月から2022年3月までの英語研究の体系的レビュー
- 症状のない個体でのスクリーニングと,軽度から中等度のCOPDの治療に関する研究が含まれています.
- 2人の査読者が論文を評価し,適正または質の高い研究からデータを抽出しました.
主要な成果:
- スクリーニングの有効性を評価した試験はありません.
- 薬理学的治療 (例えば,支氣管拡張剤,ティオトロピウム) は,中等度のCOPDの悪化と生活の質の改善に効果を示した.
- 非薬理学的介入には一貫した利点がなかった.観察研究では,特定の薬理学的薬剤の潜在的心血管リスクが認められた.
結論:
- 前回のレビューと一致し,中等度のCOPDの薬理学的治療を支持しています.
- 軽度から中度までまたは最小症状のCOPDにおける非薬理学的介入の証拠は限られている.
- 特定の集団における薬理学的治療のリスクと利益を明らかにするために,さらなる研究が必要になる可能性があります.
関連する概念動画
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease
1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


